|本期目录/Table of Contents|

[1]康华利,张继航.非小细胞肺癌生物标志物血小板及来源外泌体研究进展[J].中华肺部疾病杂志,2023,(05):731-733.[doi:10.3877/cma.j.issn.1674-6902.2023.05.036]
点击复制

非小细胞肺癌生物标志物血小板及来源外泌体研究进展(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2023年05期
页码:
731-733
栏目:
综述
出版日期:
2023-10-20

文章信息/Info

Title:
-
作者:
康华利; 张继航
400037 重庆,陆军(第三)军医大学第二附属医院心血管内科
Author(s):
-
关键词:
血小板;  外泌体;  非小细胞肺癌;  生物标志物
Keywords:
-
分类号:
R734.2
DOI:
10.3877/cma.j.issn.1674-6902.2023.05.036
摘要:
-
Abstract:
-

参考文献/References:

1 Global Cancer Observatory. Population Fact sheets.(2023). Available at: https://gco.iarc.ctsheets/populations/160-china-fact-sheets.pdf
2 吴国明, 钱桂生. 非小细胞肺癌靶向治疗研究进展及新理念[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(4): 405-408
3 Feng Wang, Xiangyang Yu, Yi Han, et al. Evaluation of the significance of subcarinal lymph node dissection in stage IB nonsmall cell lung cancer[J]. Mol Clin Oncol, 2023, 18(6): 50.
4 Mengdie Zhang, Kai Xu, Yingtao Lin, et al. Cost-effectiveness analysis of toripalimab plus chemotherapy versus chemotherapy alone for advanced non-small cell lung cancer in China [J]. Front Immunol, 2023, 14: 1169752.
5 Rijavec E, Coco S, Genova C, et al. Liquid biopsy in non-small cell lung cancer: highlights and challenges[J]. Cancers(Basel), 2019, 12: 17.
6 M.E. Daly. Determinants of platelet count in humans [J]. Haematologica, 2011, 96: 10-13.
7 Tagalakis V, Levi D, Agulnik JS, et al. High risk of deep vein thrombosis in patients with non-small cell lung cancer: a cohort study of 493 patients[J]. J Thorac Oncol, 2007, 2: 729-734.
8 Abdel-Razeq H, Mansour A, Saadeh SS, et al. The application of current proposed venous thromboembolism risk assessment model for ambulatory patients with cancer[J]. Clin Appl Thromb Hemost, 2018, 24(3): 429-433.
9 Munoz Martin AJ, Ortega I, Font C, et al. Multivariable clinical-Genetic risk model for predicting venous thromboembolic events in patients with cancer[J]. Br J Cancer, 2018, 118(8): 1056-1061.
10 Stone RL, Nick AM, McNeish IA, et al. Paraneoplastic thrombocytosis in ovarian cancer[J]. N Engl J Med, 2012, 366(7): 610-618.
11 Reddel CJ, Tan CW, Chen VM. Thrombin generation and cancer: Contributors and consequences[J]. Cancers(Basel), 2019, 11(1): 100.
12 Wiktoria Strasenburg, Jakub Józwicki, Justyna Durslewicz, et al. Tumor cell-induced platelet aggregation as an emerging therapeutic target for cancer therapy[J]. Front Oncol, 2022, 12: 909767.
13 Schlesinger M. Role of platelets and platelet receptors in cancer metastasis[J]. J Hematol Oncol, 2018, 11: 125.
14 Theresa Placke, Melanie Örgel, Martin Schaller, et al. Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells[J]. Cancer Res, 2012, 72: 440-448.
15 Alba Rodriguez-Martinez, Iris Simon-Saez, Sonia Perales, et al. A. Rodriguez-Martinez, et al. Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior[J]. Theranostics, 2022, 12: 2150-2161.
16 Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis[J]. Cancer Cell, 2011, 20: 576-590.
17 Baikun Li, Ting Zhu, Xiaohong Wu, et al. The crosstalk between lung cancer cells and platelets promotes tumor angiogenesis in vivo and in vitro[J]. J Cancer Res Clin Oncol, 2022,149(7): 3495-3511.
18 Gkolfinopoulos S, Jones RL, Constantinidou A. The emerging role of platelets in the formation of the micrometastatic niche: current evidence and future perspectives[J]. Front Oncol, 2020, 10: 374.
19 Amir Asgari, Gabriela Lesyk, Erika Poitras, et al. Platelets stimulate programmed death-ligand 1 expression by cancer cells: Inhibition by anti-platelet drugs[J]. J Thromb Haemost, 2021, 19: 2862-2872.
20 Suzuki-Inoue K. Roles of the CLEC-2-podoplanin interaction in tumor progression[J]. Platelets, 2018, 29(8): 786-792.
21 Kasthuri RS, Taubman MB, Mackman N. Role of tissue factor in cancer[J]. J Clin Oncol, 2009, 27(29): 4834-4838.
22 Best MG, In ‘t Veld SGJG, Sol N, et al. RNA sequencing and swarm intelligence-enhanced classification algorithm development for blood-based disease diagnostics using spliced blood platelet RNA[J]. Nat Protoc, 2019, 14: 1206-1234.
23 Antunes-Ferreira M, Koppers-Lalic D, Wurdinger T, et al. Circulating platelets as liquid biopsy sources for cancer detection[J]. Mol Oncol, 2020, 15: 1727-1743.
24 In ‘t Veld SGJG, Arkani M, Post E, et al. Detection and localization of early- and late-stage cancers using platelet RNA[J]. Cancer Cell, 2022, 40(9): 999-1009.
25 Best MG, Sol N, In ‘t Veld SGJG, et al. Swarm intelligence-enhanced detection of non-small-cell lung cancer using tumor-educated platelets[J]. Cancer Cell, 2017, 32(2): 238-252.
26 Meiling Sheng, Zhaohui Dong, Yanping Xie. Identification of tumor-educated platelet biomarkers of non-small-cell lung cancer[J]. Onco Targets Ther, 2018, 11: 8143-8151.
27 Xinyi Li, Lele Liu, Xingguo Song, et al. TEP linc-GTF2H2-1, RP3-466P17.2, and lnc-ST8SIA4-12 as novel biomarkers for lung cancer diagnosis and progression prediction[J]. J Cancer Res Clin Oncol, 2021, 147(6): 1609-1622.
28 Silvia D'Ambrosi, Allerdien Visser, Mafalda Antunes-Ferreira, et al. The analysis of platelet-serived circRNA repertoire as potential diagnostic biomarker for non-small cell lung cancer[J]. Cancers(Basel), 2021, 13(18): 4644.
29 Alessandro Russo, Tindara Franchina, Giuseppina R R Ricciardi, et al. Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio(dNLR), platelet-to-lymphocyte ratio(PLR), and outcome in non small cell lung cancer(NSCLC)treated with Nivolumab or Docetaxel[J]. J Cell Physiol, 2018, 233(10): 6337-6343.
30 Alberto Pavan, Lorenzo Calvetti, Alessandro Dal Maso, et al. Peripheral blood markers identify risk of immune-related toxicity in advanced non-small cell lung cancer treated with immune-checkpoint inhibitors[J]. Oncologist, 2019, 24(8): 1128-1136.
31 Ke Zhou, Jie Cao, Huahang Lin, et al. Prognostic role of the platelet to lymphocyte ratio(PLR)in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: A systematic review and meta-analysis[J]. Front Oncol, 2022, 12: 962173.
32 Na Zhang, Jianjun Jiang, Sihui Tang, et al. Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis[J]. Int Immunopharmacol, 2020, 85: 106677.
33 Zmigrodzka M, Witkowska-Piaszewicz O, Winnicka A. Platelets extracellular vesicles as regulators of cancer progression-an updated perspective[J]. Int J Mol Sci, 2020, 21(15): 5195.
34 Taus F, Meneguzzi A, Castelli M, et al. Platelet-derived extracellular vesicles as target of antiplatelet agents. What is the evidence?[J]. Front Pharmacol, 2019, 10: 1256.
35 Xing F, Liu Y, Wu SY, et al. Loss of XIST in breast cancer activates MSN-c-Met and reprograms microglia via exosomal mirna to promote brain metastasis[J]. Cancer Res, 2018, 78(15): 4316-4330.
36 Gener Lahav T, Adler O, Zait Y, et al. Melanoma-derived extracellular vesicles instigate proinflammatory signaling in the metastatic microenvironment[J]. Int. J. Cancer, 2019, 145(9): 2521-2534.
37 Peng Chen, Ying Li, Rui Liu, et al. Non-small cell lung cancer-derived exosomes promote proliferation, phagocytosis, and secretion of microglia via exosomal microRNA in the metastatic microenvironment[J]. Transl Oncol, 2023, 27: 101594.
38 Kaisa E Happonen, Sinh Tran, Matthias Mörgelin, et al. The Gas6-Axl Protein Interaction Mediates Endothelial Uptake of Platelet Microparticles[J]. J Biol Chem, 2016, 291(20): 10586-10601.
39 Anna Janowska-Wieczorek, Marcin Wysoczynski, Jacek Kijowski, et al. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer[J]. Int J Cancer, 2005, 113(5): 752-760.
40 Ren JG, Man QW, Zhang W, et al. Elevated level of circulating platelet-derived microparticles in oral cancer[J]. J Dent Res, 2016, 95(1): 87-93.
41 Chin-Chou Wang, Chia-Cheng Tseng, Huang-Chih Chang, et al. Circulating microparticles are prognostic biomarkers in advanced non-small cell lung cancer patients[J]. Oncotarget, 2017, 8(44): 75952-75967.

备注/Memo

备注/Memo:
基金项目: 国家自然科学基金面上项目(81873519)
通信作者: 张继航, Email: zhang.zjh@qq.com
更新日期/Last Update: 2023-10-20